Dilip Shanghvi

Sun Pharma; bolt-on M&A discipline

Dilip Shanghvi is founder and Managing Director of Sun Pharmaceutical Industries, India's largest listed pharma company by market capitalisation. He founded Sun Pharma in 1983 with five psychiatric products and expanded it via serial acquisitions, most notably the purchase of Ranbaxy Laboratories, creating a global generics powerhouse. His capital-allocation style prioritises distressed or undervalued targets that Sun Pharma can turnaround operationally.